Evidence map›Paper›PMID 35603235›Full record

ArticleJournal of preventive medicine and hygiene2021

Epidemiological characteristics and outcomes of COVID-19 in asymptomatic versus symptomatic patients.

Elahe Piraee, Marzieh Davoodi, Aliasghar Valipour, Mousa Ghelichi Ghojogh, Alireza Jafari, Habibollah Azarbakhsh

Abstract read
In one paragraph

Article in Journal of preventive medicine and hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elahe PiraeeSocial Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Marzieh DavoodiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Aliasghar ValipourDepartment of Public Health, Abadan Faculty of Medical Sciences, Abadan, Iran.
Mousa Ghelichi GhojoghPhD Candidate in Epidemiology, Health Management and Social Development Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Alireza JafariDepartment of Health Education and Health Promotion, School of Health, Social Development and Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
Habibollah AzarbakhshPhD Candidate in Epidemiology, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The clinical manifestations of COVID-19 are different, which can be attributed to asymptomatic carriers, acute respiratory disease and pneumonia with different severities. The aim of this study was to compare the epidemiological characteristics and outcomes of COVID-19 in patients with clinical symptoms versus asymptomatic patients. Methods: In this retrospective cohort study, the epidemiological characteristics of two groups of patients, with clinical symptoms (n = 38,630) and without clinical symptoms who were definitive cases of COVID-19 (n = 2,327) were investigated in the southwestern of Iran. Chi-square test was used to evaluate the differences between qualitative variables in the two study groups. Results: Of 40,957 patients with COVID-19, 2,327 (5.68%) were asymptomatic, of whom 1391 (59.77%) were males, 1841 patients (79.11%) had a history of contact with definite or suspected cases of COVID-19. Asymptomatic patients were older than symptomatic cases. Patients with clinical symptoms had higher mortality rate than asymptomatic patients (2.68% in symptomatic patients vs 0% in asymptomatic patients). Conclusion: According to the results of our study, the detected viral load in asymptomatic individuals was similar to that of symptomatic patients, indicating that asymptomatic infections can potentially transmit the disease. Therefore, screening and detection of asymptomatic cases is an important and key measure in prevention and early control of COVID-19 worldwide.

Indexed as

COVID-19Asymptomatic InfectionsFemaleHumansMaleRetrospective StudiesSARS-CoV-2Viral LoadAsymptomatic infectionCOVID-19Patients with clinical symptoms

Identifiers

PMID35603235
PMCPMC9104676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.